$7.5MSeed, 20 May 2026
Seed to demonstrate minimally invasive deployment in patients and pursue US commercialization.
- Amount
- $7.5M
- Stage
- Seed
- Announced
- 20 May 2026
- Lead
- Skybound Venture Capital
- Other investors
- PL Capital, IAG Capital Partners, Connecticut Innovations
- Use of funds
- Seed to demonstrate minimally invasive deployment in patients and pursue US commercialization.
- Checked
- Announced by the company
- Sources
- Neurosoft Bioelectronics closes $7.5M seed businesswire.com
Neurosoft Bioelectronics closes $7.5M seed pulse2.com